Dr. Park is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Smilow Cancer Hospital
35 Park Street, LL513
New Haven, CT 06519Phone+1 203-200-2100Fax+1 203-785-4622
Education & Training
- Yale-New Haven Medical CenterChief Residency, Radiation Oncology, 2016 - 2017
- Yale-New Haven Medical CenterResidency, Radiation Oncology, 2013 - 2017
- Beth Israel Deaconess Medical Center, Harvard Medical School2012 - 2013
- Harvard School of Public HealthMPH, Biostatistics, Epidemiology, Decision Science, 2011 - 2012
- Yale School of MedicineClass of 2012, MD, Cum Laude
- Yale UniversityBS, Neurobiology, Music, 2003 - 2007
Certifications & Licensure
- RI State Medical License 2021 - 2026
- CT State Medical License 2014 - 2025
- MA State Medical License 2012 - 2013
- American Board of Radiology Radiation Oncology
Clinical Trials
- Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer Start of enrollment: 2020 Mar 02
Roles: Principal Investigator, Contact
- Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) With Osimertinib for the Treatment of Patients With Oligoprogressive EGFR Positive Non-small Cell Lung Carcinoma Start of enrollment: 2024 Oct 09
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Future directions in the evaluation and management of newly diagnosed metastatic cancer.Eric J Lehrer, Chachrit Khunsriraksakul, Sara Garrett, Daniel M Trifiletti, Jason P Sheehan
Critical Reviews in Oncology/hematology. 2025-04-01 - Percutaneous Cryoablation of Non-small Cell Lung Cancer in Patients with Recurrence After Stereotactic Body Radiation Therapy.Adam G Fish, Henry S Park, Elizabeth Knight, Christin A Knowlton, David C Madoff
Cardiovascular and Interventional Radiology. 2025-03-11 - 4 citationsRadiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label,...Loren K Mell, Pedro A Torres-Saavedra, Stuart J Wong, Julie A Kish, Steven S Chang
The Lancet. Oncology. 2024-12-01
Press Mentions
- Smilow Announces First Administration of Unprecedented Radiotherapy TreatmentSeptember 5th, 2024
- SUDs Rates Highest in Head, Neck, and Gastric Cancer SurvivorsJanuary 16th, 2024
- YNHH’s Smilow Cancer Hospital Pioneers New Radiotherapy TechnologyMarch 9th, 2023
- Join now to see all
Professional Memberships
- Member
- Member
- American Radium Society - ARSMember
- American College of Radiation Oncology - ACROMember
External Links
- Yale Profilehttp://radonc.yale.edu/people/faculty/henry_park.profile
- LinkedInhttps://www.linkedin.com/in/henryspark
- PubMedhttps://www.ncbi.nlm.nih.gov/sites/myncbi/1Zon8WioDca5a/bibliography/41559561/public/?sort=date&direction=descending
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: